GL1X · GenesisL1 explorer

Research workbench

Crystal structure of L100I mutant HIV-1 reverse transcriptase in complex with nevirapine

Analyse Crystal structure of L100I mutant HIV-1 reverse transcriptase in complex with… in the GL1X research workbench: secondary structure, accessibility, pockets, interfaces, conservation, variants, modifications, peptides, crosslinks and neighbours on the 3D structure.

PDB
1S1U
Type
protein
Length
926 residues
Chains
2
Method
x-ray diffraction
Collection
MolNFT v1 / PDB
Contract
0xDE3723766Bc32dcACD03C17BaA400A7B36837Eba
Owner
0x3396CDB397284571d12822B4ae1189a8E22AAAAA
Molecule
Reverse transcriptase
EC
2.7.7.49
UniProt
P04585
Ligands
NVP
Pockets
17 · best druggability 0.80

Structure

x-ray diffraction · 2 distinct chains · 34% helix, 23% strand (DSSP).

ChainMoleculeTypeResiduesSecondary structureUniProt
AReverse transcriptase (EC 2.7.7.49)protein52532% helix, 23% strandP04585
BReverse transcriptase (EC 2.7.7.49)protein40137% helix, 22% strandP04585

Ligands and binding sites

  • NVP · 11-cyclopropyl-5,11-dihydro-4-methyl-6H-dipyrido[3,2-B:2',3'-e][1,4]diazepin-6-one · ligand · chains A

Binding sites are the residues within 4.5 Å of a ligand's heavy atoms.

Pockets

17 pockets found on a 1 Å grid, 8 with a druggability of 0.5 or more.

PocketVolume (ų)DruggabilityBuriednessLining residuesInside
18650.800.8275NVP
26250.700.7865empty
32030.640.8341empty
43890.610.7741empty
5680.600.9020empty

Interfaces

1 interface between chains.

  • A–B · 2431 Ų buried · 31 hydrogen bonds · protein-protein

Modifications

Observed in the structure: 1 modified (oxidation).

Compared structures

  • 1S1U · Crystal structure of L100I mutant HIV-1 reverse transcriptase in complex with nevirapine · the same entry in another collection · chain A against A, TM-score 1.00

Analyse

GL1X is a live explorer of the GenesisL1 blockchain. Turn on JavaScript for search, charts and interactive views.